-
Forward Look
It Takes a VillageImproving pediatric cancer care in developing countries
by Leah Lawrence
-
Forward Look
Paying a Steep PriceNew laws are pushing health insurers to make oral cancer drugs affordable.
by Betty Russell
-
The Power of One
A cancer survivor reflects on the stranger who gave him a second chance at life.
by Robert Henslin
-
Survivor Profile
Standing StrongDrawing on strength from her ancestors and lessons from the 1960s, cancer survivor Vernal Branch works to make a difference for the next generation.
by Regina Nuzzo
-
When Less Is More
Studies are finding that aggressive treatment, such as extensive surgery, radiation or chemotherapy, is not always necessary for cancer patients to get good results.
by Alexandra Goho
-
Yesterday & Today
Who Loves Ya, Baby?Telly Savalas met his match in bladder cancer. Earlier diagnosis and more aggressive treatment might have made a difference.
by Jocelyn Selim
-
Healthy Habits
Just Add WaterStudy finds aquatic exercise may help survivors fight fatigue.
by Stephen Ornes
-
Q&A
Writing Through ItIn a new book and on her New York Times blog, author Susan Gubar chronicles her experiences living with metastatic cancer.
by Marci A. Landsmann
-
Forward Look
The Proof of the Proton Is in the ResultProton beam radiation therapy is expensive and controversial.
by Stephen Ornes
-
Forward Look
Kids in ActionYoung cancer survivors can benefit from tailored fitness programs.
by Rabiya Tuma
Cancer Talk
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
